Pearson Nurse’s Drug Guide 2020

Description

For nursing courses covering drugs or drug administration.
A long-trusted reference guide for safe, effective drug administration
Current and comprehensive, Pearson Nurse’s Drug Guide 2020 helps clinicians administer drugs safely in any healthcare setting. Drugs are listed alphabetically by generic name and indexed by both generic and trade name – enabling quick, easy lookup. Students can get clinical information for hundreds of drugs, including adverse reactions, interactions, side effects, and the impact on lab results. The 2020 edition features 15 new monographs for drugs recently approved by the FDA.

For nursing courses covering drugs or drug administration.

A long-trusted reference guide for safe, effective drug administration

Current and comprehensive, Pearson Nurse’s Drug Guide 2020 helps clinicians administer drugs safely in any healthcare setting. Drugs are listed alphabetically by generic name and indexed by both generic and trade name – enabling quick, easy lookup. Students can get clinical information for hundreds of drugs, including adverse reactions, interactions, side effects, and the impact on lab results. The 2020 edition features 15 new monographs for drugs recently approved by the FDA.

• About the Authors
• Editorial Review Panel
• Preface
• Alphabetical Entries for Generic Drugs

Actionable clinical information for specific drugs

• The new edition features 15 new monographs for drugs recently approved by the FDA:
• Angiotensin
• Barcitinib
• Elagolix
• Erenumab
• Ertugliflozin
• Fostamatinib
• Latanoprostene Bunod
• Lofexidine
• Netarsudil
• Ozenoxacin
• Plazomicin
• Secnidazole
• Semaglutide
• Sodium Z
• Tildrakizumab

Actionable clinical information for specific drugs

• Drug monographs help nurses adjust diagnoses and interventions based on an achieved therapeutic effect, therapeutic failure, manifestation of an adverse effect, or demonstration of a learning need. Pharmacologic classifications are paired with therapeutic classifications for every drug monograph.
• New – The new edition features 15 new monographs for drugs recently approved by the FDA:
• Angiotensin
• Barcitinib
• Elagolix
• Erenumab
• Ertugliflozin
• Fostamatinib
• Latanoprostene Bunod
• Lofexidine
• Netarsudil
• Ozenoxacin
• Plazomicin
• Secnidazole
• Semaglutide
• Sodium Z
• Tildrakizumab
• Glossary of Key Terms, Clinical Conditions, and Associated Signs and Symptoms (Appendix F) provides valuable information on common assessment findings related to the therapeutic effectiveness of specific drugs.

Preparation for safe, effective drug administration

• Detailed administration information is provided for IV preparation as well as for push, continuous, or intermittent administration.
• Dosage information for patients across the lifespan – neonates, infants, adolescents, adults, and patients with obesity and renal or hepatic impairment – prepares nurses to safely administer drugs to nearly any patient.
• Students receive guidance in providing drug information to patients in hospitals, clinics, and community settings, along with related nursing implications.
• Clearly demarcated Black Box Warnings alert readers to safety concerns such as serious side effects or life-threatening risks.

Focus on drug classes and families

• A current listing of drug classifications and their associated drug prototypes serves as a valuable tool, especially for students new to pharmacology, drug families, and prototype drugs.
• Several helpful tables and charts appear in the appendices, such as US Schedules of Controlled Substances, FDA Pregnancy Information, Prescription Combination Drugs, and Herbal and Dietary Supplement Table.

Kelly M. Shields is associate dean and an associate professor of pharmacy practice at Ohio Northern University’s Raabe College of Pharmacy. She holds a doctor of pharmacy from Butler University and completed a fellowship in natural product information and research at the University of Missouri-Kansas City. She has practiced pharmacy in retail, community, and academic settings and has worked as a freelance medical writer.
Kami L. Fox is the director and chair and an associate professor in the Department of Nursing at Ohio Northern University. She holds BS and MS degrees in nursing from Wright State University in Dayton, Ohio, and a DNP from the University of Toledo. She is a certified pediatric nurse practitioner in primary care.
Christina M. Liebrecht is an assistant professor of nursing at Ohio Northern University. She holds a BS in nursing and a doctorate in nursing practice from the University of Toledo, as well as an MS degree in nursing from Walden University. She has been in nursing education for the last 19 years with a focus on medical surgical nursing, fundamentals of nursing, and community health nursing as well as the use of simulation to support student learning and safe practice. She continues to practice as a medical surgical nurse in the acute care setting.